Our Solutions   CIZUMAB 300 mg 12 ml Injection

CIZUMAB 300 mg 12 ml Injection

CIZUMAB 300 mg

*To be consumed as directed by physician.

Therapies:

Biotech Product

Composition:

Bevacizumab 300 mg / 12 ml

About CIZUMAB 300 mg 12ml Injection

Cizumab 300 mg/12 ml Injection contains Bevacizumab 300 mg/12 ml, an anti-cancer medicine used in the treatment of colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, cervical cancer, and certain brain tumors. It works by blocking the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby slowing or stopping their growth.

CIZUMAB 300 mg

*To be consumed as directed by physician.


Usage Instructions

  • Cizumab 300 mg/12 ml Injection should be administered only under the supervision of a qualified healthcare professional.
  • The dose and treatment duration are determined by the doctor based on the type of cancer, treatment response, and individual patient condition.
  • Continue treatment as advised by your oncologist.

    • Benefits and Use

  • Cizumab 300 mg/12 ml Injection is used in the treatment of colorectal cancer, ovarian cancer, cervical cancer, kidney cancer, brain tumors, and non-small cell lung cancer.
  • It works by blocking Vascular Endothelial Growth Factor (VEGF), reducing the blood supply to tumors and helping slow cancer growth and progression.

    • Safety Information

  • Alcohol: The interaction with alcohol is not known. Consult your doctor before consuming alcohol during treatment.
  • Pregnancy: Not recommended during pregnancy unless specifically prescribed by your doctor. It may harm the unborn baby.
  • Breastfeeding: Breastfeeding is not recommended during treatment as the medicine may cause harm to the infant.
  • Driving: May cause dizziness, fainting, or reduced alertness in some patients. Avoid driving or operating machinery if affected.
  • Kidney Disease: Use with caution in patients with kidney disease. Regular monitoring and dose adjustments may be required.
  • Liver Disease: Limited information is available in patients with liver disease. Consult your doctor before use.
  • Bleeding & Surgery: This medicine may increase the risk of bleeding and delay wound healing. Inform your doctor before any planned surgical procedure.

    • Ingredients

    Bevacizumab 300 mg/12 ml

    How to Use

  • This medicine is given as an intravenous (IV) infusion by a doctor or trained healthcare professional.
  • Do not self-administer.
  • Patients may require regular monitoring of blood pressure, urine protein levels, and overall treatment response during therapy.

    • Storage Information

    Store in a cool, dry place away from direct sunlight and moisture.